http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3437636-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7341210a0e57c558ee665835a6985458 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-397 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2009 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2013 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 |
| filingDate | 2017-08-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b69c4b8aa5a4b8b849d6b39ded472d41 |
| publicationDate | 2019-02-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-3437636-A1 |
| titleOfInvention | Pharmaceutical composition comprising ezetimibe |
| abstract | The invention relates to a pharmaceutical composition comprising 5 to 20 %wt. ezetimibe, 5 to 20 %wt. plastic excipient, 3 to 10 %wt. disintegrant, 1 to 12 %wt. starch, 0.5 to 1.5 %wt. silica, 0.5 to 2.5 %wt. stearic acid, wherein a weight ratio stearic acid to silica is 1:1 to 3: 1, and wherein the pharmaceutical composition of the invention comprises a further diluent and binder, and optionally surfactant. Furthermore, the invention relates to a tablet comprising the composition, and a use of the composition for manufacturing the tablet. |
| priorityDate | 2017-08-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 77.